Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease

BACKGROUND: Immune checkpoint-induced pneumonitis (ICIP) is one of the most fatal adverse events caused by immune checkpoint inhibitors (ICI) and accounts for 35% of anti-PD-[L]1-related deaths. Risk factors including thoracic radiation and use of EGFR tyrosine kinase inhibitors have been identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Emily, Umoru, Godsfavour, Ajewole, Veronica, Bernicker, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628484/
https://www.ncbi.nlm.nih.gov/pubmed/37941544
http://dx.doi.org/10.3389/fonc.2023.1283360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628484/
https://www.ncbi.nlm.nih.gov/pubmed/37941544
http://dx.doi.org/10.3389/fonc.2023.1283360

Ejemplares similares